

Browsing restrictions can be lifted for a fee.
The latest data point for Current Contract Liabilities of RXRX, as of Q1'26, stands at $32.8M USD, reflecting a significant decline from the previous quarter's $151.6M USD and marking the lowest level in the observed period. Over the timeframe from Q2'23 to Q1'26, the chart shows an initial downward trend from $105.5M USD in Q2'23 to $61.4M USD in Q2'24, followed by a sharp rebound peaking at $180.5M USD in Q4'24, likely indicating a surge in new contracts or deferred revenue recognition. Subsequent quarters exhibit a steady decline to $32.8M USD in Q1'26, suggesting potential revenue fulfillment or contract expirations, with overall volatility underscoring fluctuating business momentum in this bar chart representation.